Yazji Salim

Track

Insider profile

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return 7% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Yazji Salim's trades of Oncternal Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
278.52
Quantity 52,283
Value US$3,385,006
Transaction date
Purchase
Price
152.41
Quantity 22,557 +19.3%
Value US$3,130,083
Transaction date
Purchase
Price
115.98
Quantity 80,280 +19.1%
Value US$129,509
Transaction date
Purchase
Price
0.29
Quantity 10,000 +7.2%
Value US$2,850
Transaction date
Purchase
Price
1.69
Quantity 10,000 +17.5%
Value US$16,900
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-10-15 2024-10-14
PrS Proposed sale
52,283
278.52
US$3,385,006 		52,283 278.52 US$3,385,006
2023-04-14 2023-04-14
B Purchase
22,557 +19.3%
152.41
US$3,130,083 		22,557 +19.3% 152.41 US$3,130,083
2023-04-14 2023-04-13
B Purchase
80,280 +19.1%
115.98
US$129,509 		80,280 +19.1% 115.98 US$129,509
2023-04-14 2023-04-12
B Purchase
10,000 +7.2%
0.29
US$2,850 		10,000 +7.2% 0.29 US$2,850
2022-01-31 2022-01-27
B Purchase
10,000 +17.5%
1.69
US$16,900 		10,000 +17.5% 1.69 US$16,900